Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cerebral Pseudosclerosis

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Cerebral Pseudosclerosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (77.78)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hermann, W1
Barthel, H; Collingridge, DR; Hermann, W; Hesse, S; Kluge, R; Sabri, O; Wagner, A1
Antonini, A; Kirsch, CM; Kraft, E; Leenders, KL; Oertel, WH; Schwarz, J; Tatsch, K; Vogl, T1
Asenbaum, S; Brücke, T; Deecke, L; Kollegger, H; Oder, W; Spatt, J1
Hondl, N; Ladurner, G; Staffen, W; Trinka, E; Zenzmaier, R1
Bettin, S; Dietrich, J; Kämpfer, I; Knapp, WH; Lössner, J; Reuter, M; Schäfer, A; Seese, A; Wagner, A1
Kirsch, CM; Kraft, E; Oertel, WH; Scherer, J; Schwarz, J; Tatsch, K; Trenkwalder, C; Vogl, T; Weinzierl, M1
Arnold, G; Gasser, T; Kirsch, CM; Oertel, WH; Schwarz, J; Tatsch, K; Trenkwalder, C; Vogl, T1
Kirsch, CM; Oertel, WH; Schwarz, J; Tatsch, K1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cerebral Pseudosclerosis

ArticleYear
Morphological and functional imaging in neurological and non-neurological Wilson's patients.
    Annals of the New York Academy of Sciences, 2014, Volume: 1315

    Topics: Benzamides; Brain; Cocaine; Copper; Fluorodeoxyglucose F18; Functional Neuroimaging; Glucose; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2014

Other Studies

8 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Cerebral Pseudosclerosis

ArticleYear
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:2

    Topics: Adult; Benzamides; Brain Mapping; Cerebellum; Cocaine; Corpus Striatum; Dopamine; Female; Hepatolenticular Degeneration; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Psychometrics; Pyrrolidines; Reference Values; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon

2003
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.
    Neurology, 1994, Volume: 44, Issue:6

    Topics: Adolescent; Adult; Benzamides; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Penicillamine; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1994
Dopamine D2 receptor binding is reduced in Wilson's disease: correlation of neurological deficits with striatal 123I-iodobenzamide binding.
    Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:8-9

    Topics: Adult; Aged; Benzamides; Case-Control Studies; Corpus Striatum; Female; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Middle Aged; Pyrrolidines; Radioligand Assay; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1996
SPET investigations in extrapyramidal diseases using specific ligands.
    Nuclear medicine communications, 1997, Volume: 18, Issue:2

    Topics: Adult; Aged; Benzamides; Brain; Cocaine; Dopamine Antagonists; Hepatolenticular Degeneration; Humans; Huntington Disease; Iodine Radioisotopes; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

1997
[Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:5

    Topics: Adult; Aged; Basal Ganglia; Benzamides; Carrier Proteins; Cerebellum; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Frontal Lobe; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed

1997
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.
    Annals of neurology, 1992, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Basal Ganglia; Benzamides; Dopamine D2 Receptor Antagonists; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1992
Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1

    Topics: Adult; Benzamides; Brain; Brain Mapping; Corpus Striatum; Female; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1992
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.
    Nuclear medicine communications, 1991, Volume: 12, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Female; Hepatolenticular Degeneration; Humans; Male; Middle Aged; Parkinson Disease; Pyrrolidines; Receptors, Dopamine; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1991